Showing results (2091-2100 of 2,431) with videos related to
Sort By:
Pageof 244
Oncogene|April 27, 2018
Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanomaPatricia Reyes-Uribe, Maria Paz Adrianzen-Ruesta, Zhong Deng, et al.Health Technology Assessment (Winchester, England)|May 7, 2011
Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveysA J Avery, C Anderson, C M Bond, et al.The Biochemical Journal|June 12, 2010
Modulation of mammary cancer cell migration by 15-deoxy-delta(12,14)-prostaglandin J(2): implications for anti-metastatic therapyAnne R Diers, Brian P Dranka, Karina C Ricart, et al.BMC Health Services Research|November 6, 2014
Design and rationale of the comprehensive evaluation of risk factors in older patients with AMI (SILVER-AMI) studyJohn A Dodson, Mary Geda, Harlan M Krumholz, et al.Proceedings of the National Academy of Sciences of the United States of America|February 7, 2023
Common activities and predictive gene signature identified for genetic hypomorphs of TP53Jessica C Leung, Julia I-Ju Leu, Alexandra Indeglia, et al.Open Heart|January 16, 2021
180-day readmission risk model for older adults with acute myocardial infarction: the SILVER-AMI studyJohn A Dodson, Alexandra M Hajduk, Terrence E Murphy, et al.NPJ Precision Oncology|August 30, 2018
Tobacco biomarkers and genetic/epigenetic analysis to investigate ethnic/racial differences in lung cancer risk among smokersSharon E Murphy, Sungshim Lani Park, Silvia Balbo, et al.Journal of Thrombosis and Haemostasis : JTH|November 19, 2015
Identification and function probing of an antithrombin IIIβ conformation-specific antibodyY Jin, S Yegneswaran, J-M Gu, et al.Journal of Perinatology : Official Journal of the California Perinatal Association|September 2, 2016
Hypertensive disorders of pregnancy and outcomes of preterm infants of 24 to 28 weeks' gestationL Gemmell, L Martin, K E Murphy, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 28, 2015
Nicotine metabolite ratio (3-hydroxycotinine/cotinine) in plasma and urine by different analytical methods and laboratories: implications for clinical implementationJulie-Anne Tanner, Maria Novalen, Peter Jatlow, et al.Pageof 244